Drug company sales visits influenced doctors, study finds

Almost half of sales visits by pharmaceutical company representatives advocating the use of the drug gabapentin led to doctors stating that they intended to increase their prescription of the drug or recommend it to colleagues, according to an analysis of a survey completed by the doctors shortly after the visits.

Nearly 40 percent of the visits involved discussion of so-called "off-label" uses of the drug not approved by the Food and Drug Administration, say the authors of the study.

At the time of the visits, gabapentin was approved only for secondary treatment of a certain form of epilepsy. Off-label uses included treatment of pain, migraine, and psychiatric conditions.

"The increased intention to prescribe after these sales visits is remarkable, and is in fact greater than has been observed in other studies," says lead author Michael A. Steinman, MD, a staff physician at the San Francisco VA Medical Center (SFVAMC).

The senior author is Lisa Bero, PhD, professor of clinical pharmacy and health policy studies at the University of California, San Francisco (UCSF) and an expert on pharmaceutical industry marketing practices.

The study appears in the April 24, 2007 issue of PLoS Medicine.

The authors analyzed a survey form that chronicled 116 visits to 97 physicians by pharmaceutical sales representatives from 1995 to 1999. The forms were collected by a market research firm and became available to the researchers as the result of a lawsuit against Parke-Davis, the maker of gabapentin. The lawsuit was brought by a former employee who alleged that the company promoted gabapentin, which it sold under the name Neurontin, for uses not officially approved by the FDA.

"To me, the remarkable thing is how effective a very brief visit by a drug representative most often less than five minutes can be in influencing physicians' choices to use a drug for an unapproved indication," Bero said.


Contact: Steve Tokar
415-221-4810 x5202
University of California - San Francisco

Page: 1 2 3

Related medicine news :

1. Italian doctors get their information on medicines from drug company sales reps
2. New biotech company to commercialize novel UD gene-repair technology
3. The Clorox companys new personal care product lends a hand
4. Drug company reports should be read with caution, warn doctors
5. Spinoff company based on technology developed at OHSU enters new business phase
6. Research reveals tobacco companys role in Chinas cigarette smuggling crisis
7. Patients groups should declare pharmaceutical company funding
8. Indiana seed fund invests in breast cancer detection startup company
9. University of Utah surgeon returns from Iraq to help start-up company fight cancer
10. Insurance company rewards to doctors and hospitals may not improve care
11. Spinoff company receives $2.5 million NIH grant to build prototype scanner

Post Your Comments:

(Date:10/22/2019)... ... October 23, 2019 , ... EDC vs ... Wednesday, Oct. 30, 2019 ? 11:00 a.m.-12 p.m. EDT, http://cwinfo.centerwatch.com/cw-web19o30-edc-vs-esource?free_webinar_source=CWEvnt , ... questions. , Find answers., Mark the calendar for this FREE webinar from Cmed ...
(Date:10/17/2019)... , ... October 17, 2019 , ... Knotty Roller, the ... case, quickly broke its campaign goal– raising more than $20,000 in only eleven hours ... the crowdfunding community, who’ll be the first to enjoy the ease of use and ...
(Date:10/15/2019)... ... ... Khalieghya Dandie-Evans, a liver transplant recipient from Richmond, Calif. was chosen by ... the 131st Rose Parade® on New Year’s Day. She will represent the thousands of ... organization’s service area. , Khalieghya, 17, grew up believing it was “normal” to have ...
(Date:10/15/2019)... , ... October 15, 2019 , ... Genomenon® ... with SOPHiA GENETICS that includes incorporating the Mastermind® Genomic Search Engine ... the most up-to-date genomic research at the fingertips of clinical researchers performing genomic analysis ...
(Date:10/11/2019)... DALLAS (PRWEB) , ... October 11, 2019 , ... A ... Alliance (STA) new headquarters facility by general contractors Adolfson & Peterson Construction. The event ... of 2020 at 8190 Midtown Road in Dallas. The first of its kind in ...
Breaking Medicine News(10 mins):
(Date:10/17/2019)... ... ... Women’s concern in the wake of the July voluntary recall issued by ... a September 24 article on CBS Miami. Beverly Hills-based plastic surgeon Payam ... a number of issues, including a possible link between textured implants in general with ...
(Date:10/15/2019)... ... October 15, 2019 , ... Twiggy Bean, Ph.D., wanted ... suffering in embittered divorce battles make better decisions and become truly child focused. This ... a bully, be resilient, and STOP the cycle! Don’t be a divorce bully!” (published ...
(Date:10/11/2019)... (PRWEB) , ... October 11, 2019 , ... Based on ... see a 9 percent increase in deceased organ donors over 2018. Through August 31, ... and Transplantation Network (OPTN) national database . At this pace, the Association of ...
Breaking Medicine Technology:
Cached News: